| 書目名稱 | Gene Transfer in the Cardiovascular System |
| 副標(biāo)題 | Experimental Approac |
| 編輯 | Keith L. March |
| 視頻video | http://file.papertrans.cn/382/381995/381995.mp4 |
| 叢書名稱 | Developments in Cardiovascular Medicine |
| 圖書封面 |  |
| 描述 | The goal of gene transfer is protein expression. a process brought about by the insertion of a gene coding for a foreign protein into target cells resulting in the synthesis of the foreign protein For gene therapy, a tmnsferred therapeutic gene must be expressed at a level beneficial for the patient. This chapter provides an introductory overview of the rapidly evolving field of non-viral approaches for gene delivery to rnarnrnalian cells. Although currently there are fewer ongoing clinical trials using non-viral approaches than those using viral based systems, the number of non-viral trials is increasing. The long range goal of some research groups is the development of a genetically engineered artificial virus targeted to specific cells in the human body. An arurual conference, organized by Cambridge Healthtech Institute entitled "Artificial Self-Assembling Systems for Gene Transfer", brings together researchers interested in this field [1]. Assembly of an artificial virus is very complex; other research groups aim to develop simpler delivery systems consisting of a plasmid combined with delivery agents. Viral-based systems are very successful for gene delivery, but despite their |
| 出版日期 | Book 1997 |
| 關(guān)鍵詞 | DNA; cardiovascular; gene therapy; gene transfer; genes |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-1-4615-6277-1 |
| isbn_softcover | 978-1-4613-7881-5 |
| isbn_ebook | 978-1-4615-6277-1Series ISSN 0166-9842 |
| issn_series | 0166-9842 |
| copyright | Springer Science+Business Media New York 1997 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-8 16:29
發(fā)表于 2025-3-21 16:42:39
